Other
Pre-tax stock-based compensation cost
West Pharmaceutical Services Pre-tax stock-based compensation cost decreased by 21.4% to $6.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 407.7%, from $1.30M to $6.60M.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2015
Last reportedQ1 2026Apr 23, 2026
Metric ID:
other_allocated_share_based_compensation_expenseHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.30M | $11.40M | $5.50M | $5.50M | $6.00M | $8.50M | $7.50M | $5.90M | $5.00M | $4.30M | $5.10M | $1.30M | $7.40M | $8.40M | $6.60M |
| QoQ Change | — | +10.7% | -51.8% | +0.0% | +9.1% | +41.7% | -11.8% | -21.3% | -15.3% | -14.0% | +18.6% | -74.5% | +469.2% | +13.5% | -21.4% |
| YoY Change | — | — | — | -46.6% | -47.4% | +54.5% | +36.4% | -1.7% | -41.2% | -42.7% | -13.6% | -74.0% | +72.1% | +64.7% | +407.7% |
Range$1.30M – $11.40M
CAGR-11.9%
Avg YoY Growth+30.7%
Median YoY Growth-7.6%
Pre-tax stock-based compensation cost at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's pre-tax stock-based compensation cost?
- West Pharmaceutical Services (WST) reported pre-tax stock-based compensation cost of $6.60M in Q1 2026.
- How has West Pharmaceutical Services's pre-tax stock-based compensation cost changed year-over-year?
- West Pharmaceutical Services's pre-tax stock-based compensation cost increased by 407.7% year-over-year, from $1.30M to $6.60M.